Trial Profile
A compassionate use study of IB1000s in Niemann-Pick Disease Type C patients
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 01 Dec 2018
Price :
$35
*
At a glance
- Drugs IB 1000 (Primary)
- Indications Niemann-Pick disease type C
- Focus Adverse reactions; Expanded access; Therapeutic Use
- 01 Dec 2018 New trial record